New and experimental therapies for pulmonary hypertension.

Channick, R N; Rubin, L J

Channick, R N; Rubin, L J.

Affiliation

Channick RN; Department of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California, USA.

Clin Chest Med ; 22(3): 539-45, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11590847

Subject(s)

Epoprostenol/analogs & derivatives; Hypertension, Pulmonary/drug therapy; Animals; Antihypertensive Agents/therapeutic use; Endothelin Receptor Antagonists; Endothelins/therapeutic use; Endothelium, Vascular/physiology; Epoprostenol/therapeutic use; Humans; Hypertension, Pulmonary/physiopathology; Nitric Oxide/therapeutic use; Vasodilator Agents/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Epoprostenol / Hypertension, Pulmonary Limits: Animals / Humans Language: En Journal: Clin Chest Med Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links